These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 6151380)

  • 1. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro measurement of the beta-adrenergic blocking properties of ORF 12592, the 5-hydroxy analog of propranolol.
    Greenslade FC; Newquist KL
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):270-80. PubMed ID: 28704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
    Snavely MD; Insel PA
    Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F; Miyamoto K; Koshiura R
    Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies on the "bronchosparing" activity of celiprolol, a cardioselective beta-adrenoceptor antagonist.
    Van Inwegen RG; Khandwala A; Gordon RJ; Sutherland CA; Wolf P; Pruss TP
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):127-44. PubMed ID: 2881517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
    Golf S; Hansson V
    Scand J Clin Lab Invest; 1986 Apr; 46(2):121-30. PubMed ID: 2872714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA; Johnston CI
    Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-yohimbine binding to guinea-pig kidney and calf cerebral cortex membranes: comparison with human platelets.
    Brodde OE; Eymer T; Arroyo J
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):208-20. PubMed ID: 6320754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to adenylyl cyclase in isolated adipocytes.
    Granneman JG
    J Pharmacol Exp Ther; 1992 May; 261(2):638-42. PubMed ID: 1349644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
    Williams LT; Gore TB; Lefkowitz RJ
    J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.